Science Explorer Back to mapMap
Institution · Qiagen (France)

Most cited papers from Qiagen (France)

What are the most cited papers from Qiagen (France)?

The most cited paper from Qiagen (France) is "Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study" (Jelena V. Jovanovic et al., 2013), with 107 citations. Next come "Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay" (50) and "A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma" (45).

Showing 9 of 9 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study Jelena V. Jovanovic et al. · Leukemia Open access 17 Jul 2013 107
2 Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay Delphine Mouttet, Marick E Lae, Martial Caly et al. · PLoS ONE Open access Feb 2016 50
3 A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma Aurélie Catteau, Hélène Girardi, Florence Monville et al. · Acta Neuropathologica Communications Open access 2 Jun 2014 45
4 Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells Nanor Sirab, G. Robert, Virginie Fasolo et al. · International Journal of Molecular Sciences Open access 10 Jul 2013 36
5 Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis Éric Lippert, Olivier Mansier, Marina Migeon et al. · Haematologica Open access 16 May 2014 30
6 Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab—Response Omid Hamid, René Bruno, Marcella Fassò et al. · Clinical Cancer Research 15 May 2020 6
7 ASTER 70s UNICANCER phase III Trial: Can a genomic prognosticator help tailoring adjuvant systemic treatment for luminal breast carcinoma in elderly women? Coraline Dubot, Emmanuelle Bourbouloux, Olivier Mir et al. · Journal of Geriatric Oncology Oct 2014 1
8 Resolving hematopoietic stem versus progenitor cell potential in the mouse dorsal aorta by differential Runx1 +110 enhancer activity Giorgio Anselmi, Vincent Frontera, Christina Rode et al. · BOA (University of Milano-Bicocca) Open access 2026 0
9 Adjuvant chemotherapy for luminal breast cancer in elderly women: Feasibility of the ongoing ASTER 70S gerico UNICANCER phase III trial Emmanuelle Bourbouloux, Youssef Tazi, Hector W. Cure et al. · Journal of Geriatric Oncology Oct 2013 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.